When you become a mother, you tend to forget about your own needs because you are so focused on your child. With the baby keeping you busy all day and night, your skincare takes a backseat. It's not always changing in skin texture and looks post-pregnancy are a bad thing, but not taking care of your skin may lead to acne, melasma, stretch marks, puffy eyes, and even dark circles.
Here we are sharing simple and easy tips for you to follow, to get a glowing post-pregnancy.
As you sleep, your skin goes through a renewal cycle, by dispensing toxins and debris. So you only need a light-textured cleanser to wash your face with a face wash that is suitable for your skin type.
Take steam for 2-3 days a week, it will help you to open up your clogged pores.
Scrub & Face Pack
Use a face scrub, to remove the dead skin cells, scrub your face for like 5 minutes and wash it with normal tap water. It will help you to make your skin softer and radiant, leave the mask until it dries off.
Toner & Moisturizer
Apply toner to your face, look for clarifying toners that rebalance your pH to maintain the pH value of your skin. In the end, you only have to moisturize your face, to give hydration.
Steal Baby Products
Baby products are always mild in nature so that the baby's sensitive skin doesn't have to compromise. They are created to lock moisture in babies skin. So, you can also use them. Whether it's a body oil, lotion or cream, apply some on your skin every time you're applying them on your baby. If you do this, you can flaunt your skin, this way, you don't have to dedicate a specific time every day for your skincare.
Keep All Skincare Needs in One Place
Organize all your skincare products in one place, this organization will help you way much better than anything. Make use of your "me time" and devote it properly to pamper yourself.
Streaming Your Routine
Make a proper timetable, for your week how many days you are going to deep cleanse your skin in a week. If we talk about the baby skincare routine this is important too. As the baby's skin is too sensitive and they are interacting with such a harsh environment pollution, high temperature etc. Don't worry there are some simple and easy enough tips. Here, what you should know, with regards to bath, diapering, selecting items and that's just the beginning.
Babies need two to three baths a week in warm, not hot water to stay clean. The initial step to an extraordinary child shower is to track down the ideal temperature. Tip: Fill the bath without any more than 2 to 3 creeps of water. To keep your child from getting cold while you wash them, routinely pour cupfuls of water over their shoulders.
There are a lot of things you'll have to do for your little one when they're an infant, like changing your baby's diaper regularly, cleaning tenderly however completely each time with child wipes. Make the surface saturated yet dry simultaneously as well. There are countless myths around diaper rashes that it is caused because of the usage of diapers. But no, it is due to a lack of attention and knowledge about the correct time to change the diaper. Else it will get worse for your child.
Awareness of Products
Always read the product label before purchasing products for your infant. It's ideal to avoid chemical and alcohol-based products. Use products that are made explicitly for infants.
Newborn babies are so delicate, requiring a lot of care and attention. A single mistake or slip of mind can make things worse. Keep your infant's skin saturated, as well, so consistently have a stockpile of moisturizers around. But excessive oil can cause cradle caps, and dryness can create painful scenarios. If your child is facing such issues you need to consult a certified dermatologist.
Read More► Turn to The Humble Coconut for Skin Care
London- A team of researchers has discovered that the more severely a mother is infected with Covid-19, the more likely she is to experience preterm birth.
The researchers reported that the rate of preterm birth in nearly 1,000 pregnant women, who tested positive for SARS-CoV-2, the virus that causes Covid-19, was a function of the severity of infection.
"The more severe the SARS-CoV-2 infection, the greater the risk of preterm birth," said researcher Roberto Romero from the Wayne State University School of Medicine in the US.
"There was a dose-dependent relationship between the severity of SARS-CoV-2 infection and the risk of prematurity," Romero added.
For the study published in the American Journal of Obstetrics and Gynecology, the team included data from 14 National Health Service (NHS) maternity hospitals in the UK to assess the effects of SARS-CoV-2 infection in pregnancy.
The excess rate of premature birth, they report, is largely due to medically-induced preterm birth brought about by concerns for health of the mother, such as preeclampsia.
Preterm birth, the leading cause of perinatal morbidity and mortality worldwide, is defined as one that occurs before 37 weeks of gestation.
Two-thirds of preterm births are due to the spontaneous onset of preterm labour. The remaining third is due to medical conditions that affect either the mother or the unborn baby that necessitate delivery.
The more severe the Covid-19 infection, the greater the risk of preeclampsia, a sudden increase in blood pressure after the 20th week of pregnancy.
The condition is responsible for 76,000 maternal deaths and more than 5,00,000 infant deaths every year.
Read More► How White Blood Cells Aid in Predicting Covid-19 Severity
New York, Aug 12 (IANS) US researchers have found that people recovering from Covid-19 and those vaccinated against SARS-CoV-2 produce identical clones, or groups, of antibody-producing white blood cells.Antibodies are proteins produced by specialised white blood cells called B lymphocytes, or B cells. When a virus binds to the surface of a B cell, it stimulates the cell to divide and mature into a clone of identical cells.The mature B cells, called plasma cells, secrete millions of antibodies into the bloodstream and lymphatic system, some of which attach to the virus and prevent it from infecting its target cell.The study, published in the journal Cell Reports, identified 27 public clonotypes, genetically similar clones of antibodies, which were shared by Covid-19 survivors and by uninfected people who had been vaccinated against SARS-CoV-2."We were surprised to discover that there are so many shared antibodies between individuals after SARS-CoV-2 infection, but that is a good sign," said James Crowe, Jr., Professor of Pediatrics and Pathology, Microbiology and Immunology from Vanderbilt University Medical Center in Tennessee, US."It was encouraging to find that an mRNA vaccine also induces those clones, which in part explains why these antibodies work so well in so many people," said Crowe.Most of the public clonotypes were formed against part of the viral surface "spike" or S protein that attaches to a specific receptor on the surface of cells in the lungs and other tissues.This part of the S protein is variable, meaning that it can change, or mutate, in ways that can make the virus virtually invisible to circulating antibodies.If many people independently make the same antibody against the variable part of the S protein, this may exert selective pressure on it to mutate.Scientists believe this is what led to the delta variant of SARS-CoV-2, which is more infectious than the original strain of the virus, and much more transmissible from person to person.In this study, researchers for the first time found two public clonotypes recognising another, more conserved part of the S protein that fuses with the cell membrane. Once fusion occurs, SARS-CoV-2 enters its target cell, where it hijacks the cell's genetic machinery to copy itself.Neutralising antibodies that bind the conserved part of the S protein are of interest because this part of the protein is less likely to mutate. Variants of SARS-CoV-2 may be less likely to evade vaccines and antibody therapies when its less mutable "Achilles heel" is targeted.The findings could help scientists design more effective vaccines and antibody therapies against a broader range of variants, the researchers said.--IANSrvt/pgh
London, Aug 9 (IANS) Pre-existing antibodies against human cold coronaviruses (HCoV) can likely confer cross-protection against Covid-19 infection, suggests a study.The study, led by researchers at the Barcelona Institute for Global Health (ISGlobal), found that people who were infected by SARS-CoV-2, the virus causing Covid-19, had lower levels of HCoV antibodies.Moreover, asymptomatic individuals had higher levels of anti-HCoV IgG and IgA than those with symptomatic infections.The study, published in Nature Communications, also showed that the levels of IgG antibodies against the spike protein of SARS-CoV-2 remain stable, or even increase, seven months after infection."Although cross-protection by pre-existing immunity to common cold coronaviruses remains to be confirmed, this could help explain the big differences in susceptibility to the disease within the population," ISGlobal researcher Carlota Dobano said.For the study, the team analysed blood samples from 578 participants, taken at four different timepoints between March and October 2020.They used the Luminex technology to measure, in the same sample, the level and type of IgA, IgM or IgG antibodies to six SARS-CoV-2 antigens as well as the presence of antibodies against the four coronaviruses that cause common colds in humans. They also analysed the neutralising activity of antibodies.The results show that the majority of infections among healthcare workers occurred during the first pandemic wave -- the percentage of participants with SARS-CoV-2 antibodies increased only slightly between March and October-from 13.5 per cent to 16.4 per cent.With the exception of IgM and IgG antibodies against the nucleocapsid (N), the rest of IgG antibodies (including those with neutralising activity) remained stable over time, confirming results from other recent studies."Rather surprisingly, we even saw an increase of IgG anti-Spike antibodies in 75 per cent of the participants from month five onwards, without any evidence of re-exposure to the virus," the study's senior co-author Gemma Moncunill said. No reinfections were observed in the cohort.--IANSrvt/vd
Chennai, Aug 9 (IANS) Non-life insurer Future Generali India Insurance Company Ltd (FGII) on Monday said it has set up a dedicated Covid-19 ward for mothers and new-born at Nowrosjee Wadia Maternity Hospital in Mumbai. According to FGII, the initiative is set to benefit over 2,500 mothers and newborns. The beneficiaries would be provided with Covid-19 treatment and care.In addition, FGII has also provided medical equipment like X-ray machines, ECG machine, warmers, syringe pumps and infusion pumps as part of its corporate social responsibility (CSR) initiative.The company is a joint venture between India's Future group and Italy's Generali group."Owing to ongoing pandemic, the healthcare system has already been reeling under intense stress. At FGII, we were cognisant of the difficulties that second-wave of pandemic had unleashed, thus, post internal deliberations, we decided to extend our support to the health machinery for alleviating the challenges that expecting mothers have been facing. We are hopeful that our small contribution would support government's efforts in the war against this pandemic," Ruchika Varma, Chief Marketing Officer said.--IANSvj/vd
London, Aug 8 (IANS) The antibodies produced as a result of infection by one variant of SARS-CoV-2, the virus causing Covid-19, are able to bind to and stop other variants from entering the host cells in order to replicate, researchers have found.Understanding how some variants may be able to trigger an effective antibody response against other variants, in addition to itself, could help inform future vaccine design, said the team from Francis Crick Institute and University College London Hospitals NHS Foundation Trust (UCLH).In their study, published in the journal eLife, the scientists analysed blood samples collected from patients who had previously been infected with Covid-19 and who were admitted to UCLH for other reasons, samples from health care workers as well as samples collected from patients at different points earlier in the pandemic.They identified Covid-19 antibodies in the blood, and in the lab ran tests to see if antibodies produced after infection with one variant were able to bind to and neutralise other variants.The study included: the original strain first discovered in Wuhan, China; the dominant strain in Europe during the first wave in April 2020 (D614G); Alpha (B117), first discovered in the UK; and Beta(B1351), first discovered in South Africa.The researchers found that antibodies produced by the Alpha variant were not able to neutralise the original or D614G strains as effectively, in comparison to neutralising the Alpha variant itself.Antibodies produced against infection with the D614G strain were able to neutralise both the Alpha and original strains to a similar level as D614G.Both the Alpha and D614G strains produced antibodies which were not able to effectively neutralise the Beta strain.There are many elements of the immune system which impact how protected an individual may be against future disease. This includes memory B cells and T cells which equip the immune system to deal with evolving threats. As a result, these findings do not necessarily mean people who were infected with specific variants are less protected against others."It's important to note that most people who have been infected with the virus will not know which variant they were infected with and it is critical that everyone eligible for the vaccine takes up the opportunity because we know they are effective in some way against all known variants," said Kevin Ng, doctoral student in the Retroviral Immunology Laboratory at the Crick.--IANSrvt/vd